@incollection{,
	
					
					
					7EBCE2EFB4E7D46C0FEB64F6E923A34B
				,
	author={{mohanadradeef} and {Prof. Dr. KassimAl-Shamma} and {University of Baghdad, Iraq.}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1281134
}

@book{b0,
	
	
		,
	title={{Pharmacotherapy, A pathophysiologic approach}}
		,
	author={{
			JTDipiro
		} and {
			Robert
		} and {
			RLTalbert
		}}
		
		
		
			,
	year={2011}
		
	
	,
	note={8th ed. McGraw Hill, USA. (section6): chapter 65}

}

@incollection{b1,
	
	
		,
	title={{Longterm antiepileptic drug therapy contributes to the acceleration of atherosclerosis}}
		,
	author={{
			TYTan
		} and {
			CHLu
		} and {
			HYChuang
		}}
		
		
	
	
		,
	journal={{Epilepsia}}
		
			50
			
			,
	year={2009}
		
	

}

@incollection{b2,
	
	
		,
	title={{Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, 5. Pokrajac M}}
		,
	author={{
			PNPatsalos
		} and {
			DJBerry
		} and {
			BfdBourgeois
		}}
		
		
	
	
		,
	booktitle={{Pharmacokinetics-handbook}}
				Belgrade
		
			,
	year={2008. 2008}
		
	
	,
	note={3rd ed. Biro Graf}

}

@incollection{b3,
	
	
		,
	title={{Determination of carbamazepine in human serum by RP-HPLC}}
		,
	author={{
			ZHaina
		} and {
			ZJinchao
		} and {
			YHuizhi
		} and {
			JixueBaiquan Ch
		} and {
			Li
		}}
		
		
		
		
	
	
		,
	journal={{Modern Pharmaceutical Research}}
		
			2
			2
			
			,
	year={2009. Oct}
		
	

}

@incollection{b4,
	
	
		,
	title={{Therapeutic drug monitoring of valproic acid in pediatric epileptic patients}}
		,
	author={{
			VKSubash
		} and {
			YRadhika
		} and {
			GVijayakumar
		} and {
			RavikumarCh
		}}
		
		
		
	
	
		,
	journal={{International Bulletin of Drug Research}}
		
			1
			
			,
	year={2011}
		
	

}

@book{b5,
	
	
		,
	title={{}}
		,
	author={{
			MarieABarbara
		} and {
			GTerry
		} and {
			LPatrick
		} and {
			M
		}}
		
		
		
		
			,
	year={2008}
		
	

}

@book{b6,
	
	
		,
	title={{}}
		,
	author={{
			PrinciplesPharmacotherapy
		} and {
			UsaHill
		}}
		
		
			
		
	

}

@incollection{b7,
	
	
		,
	title={{Management of epilepsy in adolescents and adults}}
		,
	author={{
			MJBrodie
		} and {
			JAFrench
		}}
		
	
	
		,
	journal={{Lancet}}
		
			356
			
			,
	year={2000}
		
	

}

@book{b8,
	
	
		,
	title={{Antiepileptic drug monotherapy in adults: Selection and use in new-onset epilepsy}}
		,
	author={{
			RHMattson
		}}
		,
	editor={Levy RH., Mattson RH., Meldrum BS.}
		
			,
	year={2008}
		
	

}

@book{b9,
	
	
		,
	title={{Antiepileptic Drugs}}
				Philadelphia, PA
		
			,
	publisher={Lippincott Williams & Wilkins}
			
		
	
	,
	note={5th ed}

}

@incollection{b10,
	
	
		,
	title={{Effectiveness of first antiepileptic drug}}
		,
	author={{
			PKwan
		} and {
			MJBrodie
		}}
		
	
	
		,
	journal={{Epilepsia}}
		
			42
			
			,
	year={2001}
		
	

}

@incollection{b11,
	
	
		,
	title={{Efficacy and tolerability of the new antiepileptic drugs. II: Treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the}}
		,
	author={{
			JAFrench
		}}
	
	
		,
	journal={{American Epilepsy Society}}
		
			1261
			,
	year={2004}
		
	
	,
	note={Neurology}

}

@book{b12,
	
	
		,
	title={{}}
		,
	author={{
			APKimberly
		} and {
			SPJay
		} and {
			AMTracey
		}}
		
		
		
			,
	year={2009}
		
	

}

@incollection{b13,
	
	
		,
	title={{Optimizing antiepileptic treatment}}
	
	
		,
	journal={{JCOM}}
		
			,
	year={October}
		
	

}

@book{b14,
	
	
		,
	author={{
			LGoldman
		} and {
			DAusiello
		}}
		
		,
	title={{Cecil medicine}}
				Saunders, USA
		
			,
	year={2008}
			426
		
	
	,
	note={23rd ed}

}

@book{b15,
	
	
		,
	author={{
			AKowalik
		} and {
			WRimpau
		} and {
			HAdam
		}}
		
		
		,
	title={{on behalf of the TOPMAT-EPY-405 investigators}}
				
			,
	year={2008}
		
	

}

@incollection{b16,
	
	
		,
	title={{}}
	
	
		,
	journal={{Acta Neurol Scand}}
		
			117
			
		
	

}

@incollection{b17,
	
	
		,
	title={{Seizure freedom with more than one antiepileptic drug}}
		,
	author={{
			LJStephen
		} and {
			MJBrodie
		}}
		
	
	
		,
	journal={{Seizure}}
		
			11
			
			,
	year={2002}
		
	

}

@book{b18,
	
	
		,
	author={{
			SKGarg
		} and {
			MCGupta
		} and {
			SSHandu
		} and {
			VKBhargava
		}}
		
		
		
		,
	title={{Therapeutic drug monitoring of antiepileptic}}
				
			,
	year={2000}
		
	

}

@incollection{b19,
	
	
		,
	title={{Agency for healthcare research and quality. Chapters available at: www.effectivehealthcare.ahrq.gov}}
		,
	author={{
			TRipple
		} and {
			MJennifer
		} and {
			JOlivia
		}}
		
		
		EHC082-EF
	
	
		,
	journal={{J Nepal Med Assoc}}
		
			47
			11
			
			,
	year={December (2011. 2008}
			,
	publisher={AHRQ Publication No}
		
	
	,
	note={Therapeutic drug monitoring of antiepileptic drugs}

}

@incollection{b20,
	
	
		,
	title={{Interactions between antiepileptic and antipsychotic drugs}}
		,
	author={{
			FMBesag
		} and {
			DBerry
		}}
		
	
	
		,
	journal={{Drug Safety}}
		
			,
	year={2006}
		
	

}

@incollection{b21,
	
	
		,
	title={{Therapeutic monitoring of antiepileptic drugs for epilepsy}}
		,
	author={{
			TTomson
		} and {
			MDahl
		} and {
			EKimland
		}}
		
		
	
	
		,
	journal={{Cochrane Database Syst Rev}}
		
			1
			D002216
			,
	year={2007a}
		
	

}

@incollection{b22,
	
	
		,
	title={{A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy}}
		,
	author={{
			GJannuzzi
		} and {
			PCian
		} and {
			CFattore
		} and {
			GGatti
		} and {
			ABartoli
		} and {
			FMonaco
		} and {
			EPerucca
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Epilepsia}}
		
			41
			
			,
	year={2000}
		
	

}

@book{b23,
	
	
		,
	title={{Evaluation of carbamazepine therapeutic monitoring. A thesis for master of science degree, college of medicine}}
		,
	author={{
			A-JImad
		} and {
			Thanoon
		}}
		
		
			,
	year={September (1992}
		
	
	,
	note={university of Mosul}

}

@book{b24,
	
	
		,
	author={{
			FMohsen
		} and {
			HAmir
		} and {
			VNaser
		} and {
			HMohammad
		} and {
			RMahmood
		} and {
			MNaghmeh
		} and {
			ATamara
		} and {
			Sh
		}}
		
		
		
		
		
		
		
		,
	title={{Therapeutic Drug Monitoring of Valproic Acid in Patients with Monotherapy at Steady State}}
				
			,
	year={2009}
		
	

}

@incollection{b25,
	
	
		,
	title={{}}
	
	
		,
	journal={{Iranian Journal of Basic Medical Sciences Autumn}}
		
	

}

@incollection{b26,
	
	
		,
	title={{Therapeutic drug monitoring for antiepileptic drugs using HPLC: An experience at a tertiary care hospital in India}}
		,
	author={{
			DKiran
		} and {
			BPiyush
		} and {
			VeenaSingh
		} and {
			GRakesh
		} and {
			DGhalaut
		} and {
			PS
		}}
		
		
		
		
		
	
	
		,
	journal={{Neurology Asia}}
		
			15
			3
			
			,
	year={2010}
		
	

}

@incollection{b27,
	
	
		,
	title={{A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients}}
		,
	author={{
			PNPastalos
		}}
	
	
		,
	journal={{Br J Clin Pharmacol}}
		
			29
			
			,
	year={1990}
		
	

}

@book{b28,
	
	
		,
	title={{Pharmacokinetics, drug interactions and tolerability of valproic acid}}
		,
	author={{
			CLDevane
		}}
		
			,
	year={2003}
		
	

}

@incollection{b29,
	
	
		,
	title={{}}
	
	
		,
	journal={{Psychopharmacol Bull}}
		
			37
			Supplement 2
			
		
	

}

@incollection{b30,
	
	
		,
	title={{Evaluation of abnormal liver function tests}}
		,
	author={{
			JKLimdi
		} and {
			GMHyde
		}}
		
	
	
		,
	journal={{Postgrad Med J}}
		
			79
			
			,
	year={2003}
		
	

}

@incollection{b31,
	
	
		,
	title={{Hepatic enzymes' level during chronic use of anticonvulsant drugs}}
		,
	author={{
			HMauricio
		} and {
			OHCarlos
		} and {
			PPaulo
		} and {
			BBArlete
		} and {
			CArthur
		}}
		
		
		
		
	
	
		,
	journal={{Arq Neuropsiquiatr}}
		
			53
			4
			
			,
	year={1995}
		
	

}

@incollection{b32,
	
	
		,
	title={{Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children}}
		,
	author={{
			AMisra
		} and {
			AAggarwal
		} and {
			OSingh
		} and {
			SSharma
		}}
		
		
		
	
	
		,
	journal={{Pediatr Neurol}}
		
			43
			
			,
	year={2010}
		
	

}

@incollection{b33,
	
	
		,
	title={{Effect of carbamazepine on serum lipids and liver function tests}}
		,
	author={{
			AAnju
		} and {
			KManish
		} and {
			MM AFaridi
		}}
		
		
	
	
		,
	journal={{Indian Pediatrics}}
		
			42
			17
			
			,
	year={2005. September}
		
	

}

@incollection{b34,
	
	
		,
	title={{Differential but infrequent alterations of hepatic enzyme levels and thyroid hormone levels by anticonvulsant drugs}}
		,
	author={{
			JDeutsch
		} and {
			GFritsch
		} and {
			JGolles
		} and {
			HJSemmelrock
		}}
		
		
		
	
	
		,
	journal={{Arch Neurol}}
		,
	editor={Verma NP., Haidukewych D.}
		
			51
			4
			
			,
	year={1986. 1994. Apr}
		
	
	,
	note={Effects of anticonvulsive drugs on the 33}

}

@incollection{b35,
	
	
		,
	title={{Technical review on the evaluation of liver chemistry tests}}
		,
	author={{
			RichardMGreen
		} and {
			StevenFlamm
		}}
		
	
	
		,
	journal={{Gastroenterology}}
		
			123
			
			,
	year={2002}
		
	

}

@incollection{b36,
	
	
		,
	title={{Serum transaminase elevations as indicators of hepatic injury}}
		,
	author={{
			EDavid
		} and {
			Amacher
		}}
		
	
	
		,
	journal={{Regulatory Toxicology And Pharmacology}}
		
			27
			
			,
	year={1998}
		
	

}

@incollection{b37,
	
	
		,
	title={{Liver function tests in persons receiving anticonvulsant medications}}
		,
	author={{
			MWall
		} and {
			JBaird-Lambert
		} and {
			NBuchanan
		} and {
			GFarrell
		}}
		
		
		
	
	
		,
	journal={{Seizure}}
		
			1
			
			,
	year={1992}
		
	

}

@incollection{b38,
	
	
		,
	title={{The significance of serum g-glutamyl transpeptidase (g-GTP) elevation caused by antiepileptic drug(s)}}
		,
	author={{
			NHirayanagi
		} and {
			EFujii
		} and {
			TeshirogiT
		}}
		
		
	
	
		,
	journal={{Nippon Ika Daigaku Zasshi}}
		
			58
			
			,
	year={1991}
		
	
	,
	note={Using the antipyrine metabolic capacity as a parameter of microsomal enzyme activity}

}

@incollection{b39,
	
	
		,
	title={{Novel Treatment of Epilepsy}}
	
	
		,
	journal={{Humberto Foyaca Sibat}}
		
			
			,
	year={2011}
		
	
	,
	note={1st ed. InTech publishing}

}

@incollection{b40,
	
	
		,
	title={{Adverse effects of antiepileptic drugs: a brief overview of important issues}}
		,
	author={{
			JoyceACramer
		} and {
			ScottMintzer
		} and {
			JamesWheless
		} and {
			RichardHMattson
		}}
		
		
		
	
	
		,
	journal={{Expert Rev. Neurother}}
		
			10
			6
			
			,
	year={2010}
		
	

}

@book{b41,
	
	
		,
	title={{}}
		,
	author={{
			HLuders
		} and {
			JAcharya
		} and {
			Baumgartner
		}}
		
		
		
			,
	year={1998}
		
	

}

@incollection{b42,
	
	
		,
	title={{}}
	
	
		,
	journal={{Semiological seizure classification}}
		
			39
			
		
	
	,
	note={Epilepsia}

}

@incollection{b43,
	
	
		,
	title={{Classification of the international league against epilepsy: Time for reappraisal}}
		,
	author={{
			JEngel
		}}
	
	
		,
	journal={{Epilepsia}}
		
			39
			
			,
	year={1998}
		
	

}

@incollection{b44,
	
	
		,
	title={{Correlation between serum level of antiepileptic drugs and their side effects}}
		,
	author={{
			AbbasharHussein
		} and {
			AmiraAbdulgalil
		} and {
			FarougOmer
		}}
		
		
	
	
		,
	journal={{Oman Medical Journal}}
		
			25
			1
			
			,
	year={2010. January}
		
	

}

@book{b45,
	
	
		,
	title={{Pediatric Epilepsy: Diagnosis and Therapy}}
		,
	author={{
			LJWillmore
		} and {
			JWWheless
		} and {
			JMPellock
		}}
		
		
		,
	editor={Pellock JM., Bourgeois BFD., Dodson WE., Nordli DR. Jr., Sankar R.}
		
			,
	year={2008}
			,
	publisher={Demos Medical Publishing}
			
			,
	address={LLC, NY, USA}
		
	
	,
	note={Adverse effects of antiepileptic drugs}

}